نتائج البحث - Francesco Cognetti

تنقيح النتائج
  1. 1
    First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?

    First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces? حسب Alessandra Fabi, Paola Malaguti, Sabrina Vari, Francesco Cognetti

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice?

    The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice? حسب Alessandra Fabi, Chiara Falcicchio, Diana Giannarelli, Gabriella Maggi, Francesco Cognetti, Patrizia Pugliese

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives

    RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives حسب Marco Infante, Alessandra Fabi, Francesco Cognetti, Stefania Gorini, Massimiliano Caprio, Andrea Fabbri

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy

    Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy حسب Italia Falcone, Fabiana Conciatori, Chiara Bazzichetto, G. Ferretti, Francesco Cognetti, Ludovica Ciuffreda, Michèle Milella

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    mTOR Cross-Talk in Cancer and Potential for Combination Therapy

    mTOR Cross-Talk in Cancer and Potential for Combination Therapy حسب Fabiana Conciatori, Ludovica Ciuffreda, Chiara Bazzichetto, Italia Falcone, Sara Pilotto, Emilio Bria, Francesco Cognetti, Michèle Milella

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Role of mTOR Signaling in Tumor Microenvironment: An Overview

    Role of mTOR Signaling in Tumor Microenvironment: An Overview حسب Fabiana Conciatori, Chiara Bazzichetto, Italia Falcone, Sara Pilotto, Emilio Bria, Francesco Cognetti, Michèle Milella, Ludovica Ciuffreda

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?

    PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise? حسب Chiara Bazzichetto, Fabiana Conciatori, Matteo Pallocca, Italia Falcone, Maurizio Fanciulli, Francesco Cognetti, Michèle Milella, Ludovica Ciuffreda

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy

    PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy حسب Fabiana Conciatori, Chiara Bazzichetto, Italia Falcone, Ludovica Ciuffreda, G. Ferretti, Sabrina Vari, Virginia Ferraresi, Francesco Cognetti, Michèle Milella

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Benefit of taxanes as adjuvant chemotherapy for early breast cancer

    Benefit of taxanes as adjuvant chemotherapy for early breast cancer حسب Emilio Bria, Cecilia Nisticò, Federica Cuppone, Paolo Carlini, Mariangela Ciccarese, Michèle Milella, Guido Natoli, E. Terzoli, Francesco Cognetti, Diana Giannarelli

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients

    Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients حسب Virginia Ferraresi, Carmen Nuzzo, Carmine Zoccali, Ferdinando Marandino, Antonello Vidiri, Nicola Salducca, Massimo Zeuli, Diana Giannarelli, Francesco Cognetti, R. Biagini

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial

    Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial حسب Carlo Garufi, Angela Torsello, Salvatore Tumolo, Giuseppe Maria Ettorre, Massimo Zeuli, Carla Campanella, Giovanni Vennarecci, Marcella Mottolese, Isabella Sperduti, Francesco Cognetti

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies

    Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies حسب Giampaolo Tortora, Roberto Bianco, Gennaro Daniele, Fortunato Ciardiello, James A. McCubrey, Maria Rosaria Ricciardi, Ludovica Ciuffreda, Francesco Cognetti, Agostino Tafuri, Michèle Milella

    منشور في 2007
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis

    Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis حسب Emilio Bria, Michèle Milella, Federica Cuppone, Silvia Novello, A. Ceribelli, V. Vaccaro, Isabella Sperduti, Alain Gelibter, Giorgio V. Scagliotti, Francesco Cognetti, Diana Giannarelli

    منشور في 2011
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology

    Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology حسب Chiara Bazzichetto, Claudio Luchini, Fabiana Conciatori, Vanja Vaccaro, Ilaria Di Cello, Paola Mattiolo, Italia Falcone, G. Ferretti, Aldo Scarpa, Francesco Cognetti, Michèle Milella

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Gemcitabine‐based combinations for inoperable pancreatic cancer: Have we made real progress?

    Gemcitabine‐based combinations for inoperable pancreatic cancer: Have we made real progress? حسب Emilio Bria, Michèle Milella, Alain Gelibter, Federica Cuppone, Maria Simona Pino, Enzo Maria Ruggeri, Paolo Carlini, Cecilia Nisticò, E. Terzoli, Francesco Cognetti, Diana Giannarelli

    منشور في 2007
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    PTEN: Multiple Functions in Human Malignant Tumors

    PTEN: Multiple Functions in Human Malignant Tumors حسب Michèle Milella, Italia Falcone, Fabiana Conciatori, Ursula Cesta Incani, Anais Del Curatolo, Nicola Inzerilli, Carmen Nuzzo, Vanja Vaccaro, Sabrina Vari, Francesco Cognetti, Ludovica Ciuffreda

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

    Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine حسب Giulio Metro, Jennifer Foglietta, Michelangelo Russillo, Lucia Stocchi, Antonello Vidiri, Diana Giannarelli, Lucio Crinò, Paola Papaldo, Marcella Mottolese, Francesco Cognetti, Alessandra Fabi, Stefania Gori

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response

    Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response حسب Fabio Valenti, Italia Falcone, Sara Ungania, Flora Desiderio, Patrizio Giacomini, Chiara Bazzichetto, Fabiana Conciatori, Enzo Gallo, Francesco Cognetti, Gennaro Ciliberto, Aldo Morrone, Antonino Guerrisi

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials

    Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials حسب Fotios Loupakis, Emilio Bria, Vanja Vaccaro, Federica Cuppone, Michèle Milella, Paolo Carlini, Chiara Cremolini, Lisa Salvatore, Alfredo Falcone, Paola Muti, Isabella Sperduti, Diana Giannarelli, Francesco Cognetti

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

    Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma حسب Michele Maio, Andrzej Maćkiewicz, Alessandro Testori, Uwe Trefzer, Virginia Ferraresi, Jacek Jassem, Claus Garbe, Thierry Lesimple, B. Guillot, Pere Gascón, Katalin Gilde, Roberto Camerini, Francesco Cognetti

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: